Revisiting the role of ABC transporters in multidrug-resistant cancer

RW Robey, KM Pluchino, MD Hall, AT Fojo… - Nature Reviews …, 2018 - nature.com
Most patients who die of cancer have disseminated disease that has become resistant to
multiple therapeutic modalities. Ample evidence suggests that the expression of ATP …

Molecular mechanisms of treatment resistance in glioblastoma

A Ou, WKA Yung, N Majd - International journal of molecular sciences, 2020 - mdpi.com
Glioblastoma is the most common malignant primary brain tumor in adults and is almost
invariably fatal. Despite our growing understanding of the various mechanisms underlying …

Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation

Y Kim, J Chen - Science, 2018 - science.org
The multidrug transporter permeability (P)–glycoprotein is an adenosine triphosphate (ATP)–
binding cassette exporter responsible for clinical resistance to chemotherapy. P-glycoprotein …

[PDF][PDF] P-glycoprotein: New insights into structure, physiological function, regulation and alterations in disease

IIA Juvale, AAA Hamid, KB Abd Halim, ATC Has - Heliyon, 2022 - cell.com
The multidrug resistance phenomenon presents a major threat to the pharmaceutical
industry. This resistance is a common occurrence in several diseases and is mediated by …

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

RJ Kathawala, P Gupta, CR Ashby Jr, ZS Chen - Drug resistance updates, 2015 - Elsevier
ATP-binding cassette (ABC) transporters represent one of the largest and oldest families of
membrane proteins in all extant phyla from prokaryotes to humans, which couple the energy …

Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans

MS Jin, ML Oldham, Q Zhang, J Chen - Nature, 2012 - nature.com
Abstract P-glycoprotein (P-gp) is an ATP-binding cassette transporter that confers multidrug
resistance in cancer cells,. It also affects the absorption, distribution and clearance of cancer …

The biochemistry of P-glycoprotein-mediated multidrug resistance

JA Endicott, V Ling - Annual review of biochemistry, 1989 - annualreviews.org
Multidrug resistance (MDR) is a unique phenomenon in thc study of cellular drug resistance.
Cell lines exhibiting this phenotype have been selected for resistance to a single cytotoxic …

[HTML][HTML] The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

MM Gottesman, V Ling - FEBS letters, 2006 - Elsevier
The discovery and characterization of P-glycoprotein, an energy-dependent multidrug efflux
pump, as a mechanism of multidrug resistance in cancer is generally accepted as a …

MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy

DM Tishler, KI Weinberg, DR Hinton, N Barbaro… - …, 1995 - Wiley Online Library
Why some patients with seizures are successfully treated with antiepileptic drugs (AEDs)
and others prove medically intractable is not known. Inadequate intraparenchymal drug …

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

NY Frank, A Margaryan, Y Huang, T Schatton… - Cancer research, 2005 - AACR
Enhanced drug efflux mediated by ABCB1 P-glycoprotein and related ATP-binding cassette
transporters is one of several mechanisms of multidrug resistance thought to impair …